A Study Comparing Begelomab Versus Other Treatments Options For The Treatment Of Patients With Steroid Refractory Acute Graft Versus Host Disease (SR-aGvHD) Using A Matched Paired Analysis.
Phase of Trial: Phase IV
Latest Information Update: 30 Jan 2017
At a glance
- Drugs Begelomab (Primary) ; Alpha 1-antitrypsin; Antithymocyte globulin; Cyclophosphamide; Etanercept; Mycophenolate; Sirolimus; Steroids
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 30 Jan 2017 New trial record
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.